Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Daunorubitec Daunorubicin Injection 20mg:
Daunorubitec Injection, containing 20 mg of Daunorubicin, is a powerful chemotherapeutic agent used primarily in the treatment of acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL). As an anthracycline antibiotic, Daunorubicin interferes with the DNA replication process in cancer cells, effectively inhibiting their growth and proliferation.
Uses of Daunorubitec Daunorubicin Injection 20mg:
Daunorubitec is indicated for:
Treatment of acute myeloid leukemia (AML)
Treatment of acute lymphocytic leukemia (ALL)
Part of combination chemotherapy regimens for various cancers
Benefits of Daunorubitec Daunorubicin Injection 20mg:
Effective in targeting and killing cancer cells
Used in established chemotherapy protocols for leukemia
Reduces the proliferation of malignant cells
Can be combined with other chemotherapeutic agents for enhanced efficacy
Mechanism of Action of Daunorubitec Daunorubicin Injection 20mg:
Daunorubicin, the active ingredient in Daunorubitec, works by intercalating DNA strands and inhibiting the enzyme topoisomerase II. This action prevents the replication of DNA and the transcription of RNA, leading to cell cycle arrest and apoptosis (programmed cell death) of cancer cells. This mechanism helps in reducing the number of cancer cells and controlling the spread of leukemia.